Home

Genau kompakt Variable non ligand estrogen pathway nf kappa fulvestrant Tagebuch Regen Ingenieurwesen

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of  action | British Journal of Cancer
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer

Estrogen receptor functional domains and signal transduction schemes.... |  Download Scientific Diagram
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram

Estrogen receptor signaling as a target for novel breast cancer  therapeutics - ScienceDirect
Estrogen receptor signaling as a target for novel breast cancer therapeutics - ScienceDirect

Estrogen Receptor Pathway | Progestogen Rectieptor Signaling
Estrogen Receptor Pathway | Progestogen Rectieptor Signaling

Dual-mechanism estrogen receptor inhibitors | PNAS
Dual-mechanism estrogen receptor inhibitors | PNAS

Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for  Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of  Medicinal Chemistry
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry

Dual-mechanism estrogen receptor inhibitors | PNAS
Dual-mechanism estrogen receptor inhibitors | PNAS

Cross-talk between nuclear receptors and nuclear factor κB | Oncogene
Cross-talk between nuclear receptors and nuclear factor κB | Oncogene

Regulation of estrogen receptor signaling in breast carcinogenesis and  breast cancer therapy. - Abstract - Europe PMC
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC

Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017  - Reproductive Medicine and Biology - Wiley Online Library
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library

New insights into acquired endocrine resistance of breast cancer
New insights into acquired endocrine resistance of breast cancer

Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... |  Download Scientific Diagram
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram

Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor  microenvironment - Abstract - Europe PMC
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC

Signaling pathways and steroid receptors modulating estrogen receptor α  function in breast cancer
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer

EREs).
EREs).

New insights into acquired endocrine resistance of breast cancer
New insights into acquired endocrine resistance of breast cancer

Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE

Endocrinotherapy resistance of prostate and breast cancer: Importance of  the NF‑κB pathway (Review)
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)

Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen  Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase |  PLOS ONE
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE

The NF-KB pathway and endocrine therapy resistance in breast cancer in:  Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)

Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer  Stemness: Elucidating Molecular Mechanisms and Clinical Significance
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance

Non-classical genomic estrogen receptor (ER)/specificity protein and  ER/activating protein-1 signaling pathways in: Journal of Molecular  Endocrinology Volume 41 Issue 5 (2008)
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008)

A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and  Genomic Signaling
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling

The role of estrogen receptor beta in breast cancer | Biomarker Research |  Full Text
The role of estrogen receptor beta in breast cancer | Biomarker Research | Full Text

A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and  Genomic Signaling.,Cell Chemical Biology - X-MOL
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL